StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HEMORGANIC.BO$19.31-0.57%
Fair $19.31+0.0%

HEMORGANIC.BO

Hemo Organic Limited

Industrials / ConglomeratesBSE

$19.31

-0.11 (-0.57%)

Fairly Valued+0.0%Fair Value $19.31Fund rank 24/100 · Data gapFallback financials|
SA 48/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-3.6M · quality 43.7/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 0/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific holding-company NAV/SOTP model required: targets are disabled until look-through holdings, debt and discount data exists. ROE is -1.1%, below the 5% threshold
Thesis & Journal · HEMORGANIC.BOLocal privado en este navegador · Hemo Organic Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$67M

P/E

41.1x

↑

EV/EBITDA

317.6x

↑

ROE

-108.2%

↓

Gross Margin

8.9%

↓

Debt/Equity

-9.77

↓
52-Week Range$19
$8$23

TradingView lightweight chart

HEMORGANIC.BO price, volumen y niveles de valoración

Último $19.31Periodo -79.9%
Fair value: $19.31

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+607.1%

FCF CAGR

—

FCF margin

-15.0%

FCF / Net income

-2.21x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $24.1M · net income $1.6M · FCF $-3.6M

2022-FY → 2025-FY

Gross margin

8.9%+45.4% pts

Operating margin

-1.7%+908.9% pts

Net margin

6.8%+919.9% pts

FCF margin

-15.0%+49.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$24.1M$24.1M$224000.00$48000.00$68300.00
Net Income$1.6M$1.6M$-2.6M$-546000.00$-623680.00
EBITDA$257000.00$257000.00$-2.6M$-546000.00$-622640.00
EPS0.470.47-0.76-0.16-0.18
Gross Margin8.9%8.9%31.7%66.7%-36.5%
Operating Margin-1.7%-1.7%-1088.4%-1135.4%-910.7%
Net Margin6.8%6.8%-1179.0%-1137.5%-913.1%
Balance Sheet
Debt/Equity-9.77-9.77-3.92-0.6910.24
Cash Flow
Free Cash Flow$-3.6M$-3.6M$-11.9M$1.1M$-44290.00
Returns
ROE-108.2%-108.2%83.7%106.6%-1821.5%
Valuation
P/E41.0941.09———
EV/EBITDA317.64317.64———
P/B————4215.97
Growth & Yield
Revenue Growth10678.1%10678.1%366.7%-29.7%—
EPS Growth161.8%161.8%-375.0%11.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

53.9%

muy exigente

EPS terminal req.

$1.71

Spread vs growth

107.9%

5Y implied EPS CAGR

34.6%

muy exigente

EPS terminal req.

$2.07

Spread vs growth

127.3%

10Y implied EPS CAGR

21.7%

exigente

EPS terminal req.

$3.34

Spread vs growth

140.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +62.4%

Total return

+62.4%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.76 → 0.47

Residual

+62.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+62.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.